Navigation Links
Discovery opens door to 'personalized' asthma therapy
Date:1/17/2008

GALVESTON, Texas In the last few years, personalized medicine using genetic or other molecular biology-based diagnostic tests to customize treatment for a particular patient has emerged as a powerful new tool for health care.

Therapy guided by genetic testing has proven highly successful in treating some types of leukemia and breast and lung cancer. Similar personalized therapies are on the horizon for other types of cancer, as well as diabetes, heart disease and other deadly disorders.

Now, University of Texas Medical Branch at Galveston (UTMB) researchers and their colleagues elsewhere have taken the first steps toward bringing the methods of personalized medicine to asthma.

Applying state-of-the-art protein screening techniques to samples taken from 84 asthmatic volunteers, theyve made the first identification of different subtypes of asthma based on distinct protein profiles, unique combinations of 10 or more proteins with which they are associated.

One of these profiles corresponds to a variety of severe, treatment-resistant asthma that, while rare, is responsible for 40 to 50 percent of the total health care costs associated with the disease.

We know that in asthma some people respond to very specific types of therapies and others dont, said Dr. Allan Brasier, director of UTMBs Sealy Center for Molecular Medicine and a senior author of a paper on the study appearing in the just-published January issue of the Journal of Allergy and Clinical Immunology (online at http://journals.elsevierhealth.com/periodicals/ymai). Being able to discover different asthma subtypes should allow us to tailor our treatments to increase the odds of a positive response, Brasier added.

To obtain their samples, researchers squirted a small amount of saline solution through tiny tubes into the anesthetized volunteers lungs. They then sucked the saline back out, bringing with it proteins washed free from walls of the network of air passages and sacs in the lungs (which swell closed when they are inflamed during an asthma attack).

In each sample, we measured 25 different cytokines, inflammatory signaling proteins that play a very important role in asthma, Brasier said. We found that our samples fell into one group associated with severe asthma, another group that looks like it represents less severe disease, and two additional groups whose significance we dont yet understand.

The unknown protein profiles, Brasier said, could be produced by types of asthma that respond differently to treatment, or that are generated by different genetic or environmental sources. These and other as-yet-undiscovered protein patterns may eventually be used to diagnose types of asthma aggravated by cigarette smoke, for example, or that cause a steady decline in lung function over a number of years.

Until now, all we knew was that asthma was a disease that manifested itself in many different ways, Brasier said. By using these patterns of multiple different proteins, we can start defining those different subtypes much more accurately which is very useful for trying to identify which ones will respond to which treatments.

According to Brasier, clinical applications of asthma protein profiling will have to await the discovery of additional protein patterns to match with other subtypes of asthma, as well as more sensitive tests that would allow for less invasive sampling techniquesa blood test, for example, or an analysis of exhaled breath.

Were still a little bit away from treating people, but thats coming, Brasier said. This is the proof of principle that you can apply proteomic patterns to personalized medicine in asthma.


'/>"/>

Contact: Tom Curtis
tcurtis@utmb.edu
409-772-2455
University of Texas Medical Branch at Galveston
Source:Eurekalert

Related medicine news :

1. Linguamatics and 81qd Sign Multi-Year Collaboration in Knowledge Discovery for Product Life Cycle Management
2. Fight against hay fever and other allergies helped by new immune system discovery
3. Discovery Healths Fifth Annual National Body Challenge Takes a Stand Against Obesity by Offering the Keys to Adopting a Healthy, Active Lifestyle
4. Overweight Twins Battle the Bulge and Gain A New Lease on Life in National Body Challenge: Twins Edition on Discovery Health
5. Kaiser Permanente and Discovery Health Team Up to Fight Childhood Obesity Epidemic
6. Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award
7. OHSU Cancer Institute research discovery opens new window to understanding chronic myeloid leukemia
8. Orion Pharma Selects ChemDiv as A Partner in Drug Discovery Services
9. BioDiscovery Joins Illumina Connect Bioinformatics Program
10. Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic
11. Beactica Announces Drug Discovery Collaboration With Arrow Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... 24, 2016 , ... Puradigm® & Innovative Solutions today announced ... and processing operations at its production facility, and opened its first two dispensaries ... manufacturer of a complete system of proactive air and surface purification solutions for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at www.diabetesscholars.org by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
Breaking Medicine Technology: